176 related articles for article (PubMed ID: 8388357)
1. Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage.
Leizorovicz A; Bara L; Samama MM; Haugh MC
Haemostasis; 1993 Mar; 23 Suppl 1():89-98. PubMed ID: 8388357
[TBL] [Abstract][Full Text] [Related]
2. Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.
Bara L; Leizorovicz A; Picolet H; Samama M
Thromb Res; 1992 Mar; 65(4-5):641-50. PubMed ID: 1319619
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Harenberg J; Roebruck P; Heene DL
Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
[TBL] [Abstract][Full Text] [Related]
5. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
Mätzsch T; Bergqvist D; Fredin H; Hedner U
Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
[TBL] [Abstract][Full Text] [Related]
7. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
8. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
9. Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group.
Liezorovicz A; Picolet H; Peyrieux JC; Boissel JP
Br J Surg; 1991 Apr; 78(4):412-6. PubMed ID: 1851649
[TBL] [Abstract][Full Text] [Related]
10. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
Boneu B
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
[TBL] [Abstract][Full Text] [Related]
11. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
[TBL] [Abstract][Full Text] [Related]
12. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
[TBL] [Abstract][Full Text] [Related]
13. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
14. [Perioperative prevention of thromboembolism with standard heparin and low molecular weight heparin, evaluation of postoperative hemorrhage. A double-blind, prospective, randomized and mono-center study].
Hoffmann R; Largiadèr F
Langenbecks Arch Chir; 1992; 377(5):258-61. PubMed ID: 1328784
[TBL] [Abstract][Full Text] [Related]
15. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
Samama M; Combe S
Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential of low molecular weight heparins.
Levine MN; Hirsh J
Baillieres Clin Haematol; 1990 Jul; 3(3):545-54. PubMed ID: 2176904
[TBL] [Abstract][Full Text] [Related]
17. Orgaran in the prevention of deep vein thrombosis in stroke patients.
Turpie AG
Haemostasis; 1992; 22(2):92-8. PubMed ID: 1379969
[TBL] [Abstract][Full Text] [Related]
18. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
[TBL] [Abstract][Full Text] [Related]
19. Prevention of post-operative thromboembolism in general surgery with enoxaparin: preliminary findings.
Haas S; Flosbach CW
Acta Chir Scand Suppl; 1990; 556():96-102. PubMed ID: 1963023
[TBL] [Abstract][Full Text] [Related]
20. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
Onarheim H; Lund T; Heimdal A; Arnesjø B
Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
